PDGF-BB Production via Plant and Inositol Derivatives
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for promoting mesenchymal stem cell production and stabilization are limited, particularly in regenerative medicine, due to ethical concerns with embryonic stem cells and inefficiencies with induced pluripotent stem cells, and there is a need for effective agents that enhance platelet-derived growth factor-BB (PDGF-BB) production.
Innovation Solution
The use of cowberry, mangosteen, scutellaria root, inositol, and inositol phosphate derivatives as active ingredients to promote PDGF-BB production, which in turn accelerates mesenchymal stem cell production and stabilization, effectively addressing the limitations of existing technologies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If embryonic stem cells are used for regenerative medicine, then pluripotency and self-replication properties are achieved, but ethical problems arise due to use of fertilized eggs
Solution Approach 1:
The invention segments the stem cell source problem by separating embryonic stem cells (with pluripotency but ethical issues) from adult mesenchymal stem cells (with ethical acceptance but limited differentiation capacity). The patent uses PDGF-BB as a selective agent to isolate and culture specific stem cell populations from adult tissues, achieving both ethical compliance and functional effectiveness.
Solution Approach 2:
The patent introduces PDGF-BB as an intermediary substance that mediates between the ethical constraint (no embryonic cells) and the functional requirement (pluripotency). PDGF-BB serves as a signaling molecule that selectively promotes the proliferation and maintenance of adult mesenchymal stem cells, effectively bridging the gap between ethical considerations and regenerative capability.
2Reliability
If induced pluripotent stem cells are used, then properties similar to embryonic stem cells are achieved, but cell canceration and creation efficiency problems occur
Solution Approach 1:
The patent employs PDGF-BB as a temporary, controllable growth factor that acts only during the specific culture period needed to expand mesenchymal stem cells. This short-acting mediator avoids the permanent genetic modifications required for iPS cell creation, eliminating canceration risks while providing sufficient pluripotency for the intended application.
Solution Approach 2:
The invention changes the biological parameters of adult mesenchymal stem cells through PDGF-BB treatment, inducing them to proliferate and maintain stemness without requiring reprogramming. This parameter-based approach (using growth factor concentration and culture conditions) replaces the genetic reprogramming approach, avoiding integration mutations and canceration while achieving similar functional outcomes.
3Object-affected harmful factors
If mesenchymal stem cells are isolated from adult tissues, then ethical problems are avoided, but production efficiency and stabilization are limited
Solution Approach 1:
The patent establishes continuous culture conditions using PDGF-BB supplementation that maintains mesenchymal stem cell proliferation and prevents differentiation over extended periods. This continuous exposure to the growth factor creates a sustained productive state, allowing large-scale expansion of stem cell populations from adult tissues without loss of viability or stemness.
Solution Approach 2:
The invention implements a feedback mechanism where PDGF-BB levels are maintained at optimal concentrations to continuously signal mesenchymal stem cells to proliferate and resist differentiation. The growth factor creates a positive feedback loop that reinforces stem cell identity and proliferation, significantly improving production efficiency and long-term stabilization of cultured populations.
Data Source
AI summary
An agent comprising one or more components selected from among cowberry derivatives, mangosteen derivatives, scutellaria root derivatives, inositol and inositol phosphate, as an active ingredient, is a novel agent that can effectively promote production of platelet-derived growth factor-BB (PDGF-BB), which contributes to production of mesenchymal stem cells and stabilization of stem cells.